XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
 12 Months Ended
Dec. 31, 2022
Document Information Line Items  
Entity Registrant Name ABVC BIOPHARMA, INC.
Document Type S-1/A
Amendment Flag true
Amendment Description ABVC BioPharma, Inc. is filing this Amendment No. 3 (this “Amendment No. 3”) to the Registration Statement on Form F-1 (Registration No. 333-271416), originally filed on April 24, 2023 and amended on May 10, 2023 and June 1, 2023 (as amended, the “Registration Statement”), as an exhibits-only filing to provide an updated auditor consent as Exhibit 23.2. Accordingly, this amendment consists only of the facing page, this explanatory note, Item 16(a) of Part II of the Registration Statement, the signature page to the Registration Statement and the filed exhibits. The remainder of the Registration Statement is unchanged and has therefore been omitted.No additional securities are being registered under this Pre-Effective Amendment No. 3. All applicable registration fees were previously paid.
Entity Central Index Key 0001173313
Entity Filer Category Non-accelerated Filer
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Entity Small Business true
Entity Emerging Growth Company false
Entity Incorporation, State or Country Code NV